Package 80070-220-33

{"route": ["TOPICAL"], "spl_id": "2e81b590-9c95-4fcf-e063-6394a90ab555", "openfda": {"nui": ["N0000185508", "N0000175629", "N0000184306", "M0000728"], "unii": ["U3RSY48JW5"], "rxcui": ["238910", "1052633"], "spl_set_id": ["dcc37403-0192-4658-bb7a-059273ce0047"], "pharm_class_cs": ["Allergens [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_epc": ["Standardized Chemical Allergen [EPC]"], "manufacturer_name": ["Foundation Consumer Brands"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 BLISTER PACK (80070-220-33)  / 9 g in 1 TUBE", "package_ndc": "80070-220-33", "marketing_start_date": "20210915"}], "brand_name": "Anbesol Maximum Strength", "product_id": "80070-220_2e81b590-9c95-4fcf-e063-6394a90ab555", "dosage_form": "GEL", "pharm_class": ["Allergens [CS]", "Cell-mediated Immunity [PE]", "Increased Histamine Release [PE]", "Standardized Chemical Allergen [EPC]"], "product_ndc": "80070-220", "generic_name": "BENZOCAINE", "labeler_name": "Foundation Consumer Brands", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Anbesol", "brand_name_suffix": "Maximum Strength", "active_ingredients": [{"name": "BENZOCAINE", "strength": "200 mg/g"}], "application_number": "M022", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210915", "listing_expiration_date": "20261231"}